- Home
- MAIA vs BODI Comparison
MAIA vs BODI Comparison
Compare MAIA & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- BODI
- Stock Information
- Founded
- MAIA 2018
- BODI 1998
- Country
- MAIA United States
- BODI United States
- Employees
- MAIA N/A
- BODI N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- BODI Industrial Machinery/Components
- Sector
- MAIA Health Care
- BODI Industrials
- Exchange
- MAIA Nasdaq
- BODI Nasdaq
- Market Cap
- MAIA 52.8M
- BODI 46.0M
- IPO Year
- MAIA 2022
- BODI N/A
- Fundamental
- Price
- MAIA $1.85
- BODI $7.94
- Analyst Decision
- MAIA
- BODI Strong Buy
- Analyst Count
- MAIA 0
- BODI 3
- Target Price
- MAIA N/A
- BODI $12.33
- AVG Volume (30 Days)
- MAIA 355.9K
- BODI 11.4K
- Earning Date
- MAIA 03-20-2025
- BODI 03-10-2025
- Dividend Yield
- MAIA N/A
- BODI N/A
- EPS Growth
- MAIA N/A
- BODI N/A
- EPS
- MAIA N/A
- BODI N/A
- Revenue
- MAIA N/A
- BODI $451,432,000.00
- Revenue This Year
- MAIA N/A
- BODI N/A
- Revenue Next Year
- MAIA N/A
- BODI N/A
- P/E Ratio
- MAIA N/A
- BODI N/A
- Revenue Growth
- MAIA N/A
- BODI N/A
- 52 Week Low
- MAIA $1.24
- BODI $5.14
- 52 Week High
- MAIA $5.99
- BODI $11.31
- Technical
- Relative Strength Index (RSI)
- MAIA 44.20
- BODI 62.87
- Support Level
- MAIA $1.83
- BODI $6.51
- Resistance Level
- MAIA $1.94
- BODI $8.01
- Average True Range (ATR)
- MAIA 0.15
- BODI 0.61
- MACD
- MAIA 0.01
- BODI 0.07
- Stochastic Oscillator
- MAIA 15.09
- BODI 80.56
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in two operating segments, Beachbody and Other.